139 related articles for article (PubMed ID: 21090348)
1. [Serum proteomic study of prostate cancer with bone metastasis].
Zhang XM; Shen Y; Xianyu ZQ
Zhonghua Nan Ke Xue; 2010 Aug; 16(8):721-5. PubMed ID: 21090348
[TBL] [Abstract][Full Text] [Related]
2. [Comparative proteomics of the serum in patients with nasopharyngeal carcinoma: a study with two-dimensional electrophoresis and MALDI-TOF-MS].
Liao QL; Chen XD; Zhao L; Ding YQ
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):154-8. PubMed ID: 18250030
[TBL] [Abstract][Full Text] [Related]
3. Characterization of proteins in human pancreatic cancer serum using differential gel electrophoresis and tandem mass spectrometry.
Yu KH; Rustgi AK; Blair IA
J Proteome Res; 2005; 4(5):1742-51. PubMed ID: 16212428
[TBL] [Abstract][Full Text] [Related]
4. Proteomic analysis of prostate cancer metastasis-derived prostasomes.
Ronquist KG; Ronquist G; Larsson A; Carlsson L
Anticancer Res; 2010 Feb; 30(2):285-90. PubMed ID: 20332430
[TBL] [Abstract][Full Text] [Related]
5. Profiling protein markers associated with lymph node metastasis in prostate cancer by DIGE-based proteomics analysis.
Pang J; Liu WP; Liu XP; Li LY; Fang YQ; Sun QP; Liu SJ; Li MT; Su ZL; Gao X
J Proteome Res; 2010 Jan; 9(1):216-26. PubMed ID: 19894759
[TBL] [Abstract][Full Text] [Related]
6. Proteomic identification of serum biomarkers for gastric cancer using multi-dimensional liquid chromatography and 2D differential gel electrophoresis.
Liu W; Liu B; Cai Q; Li J; Chen X; Zhu Z
Clin Chim Acta; 2012 Jul; 413(13-14):1098-106. PubMed ID: 22446497
[TBL] [Abstract][Full Text] [Related]
7. [Differential proteomic analysis of human colorectal carcinoma cell lines SW620 and SW480 with different metastatic potentials].
Qu LJ; Ding YQ; Liang L
Di Yi Jun Yi Da Xue Xue Bao; 2005 Oct; 25(10):1211-5, 1220. PubMed ID: 16234091
[TBL] [Abstract][Full Text] [Related]
8. [A proteomic study of the serum proteins in BPH and HGPIN patients].
Gu XJ; Zhu QY; Yuan L; Su J; Huang WZ; Zhang Y; Sun ZY
Zhonghua Nan Ke Xue; 2008 Jan; 14(1):62-6. PubMed ID: 18297816
[TBL] [Abstract][Full Text] [Related]
9. Proteomic tracking of serum protein isoforms as screening biomarkers of ovarian cancer.
Ahmed N; Oliva KT; Barker G; Hoffmann P; Reeve S; Smith IA; Quinn MA; Rice GE
Proteomics; 2005 Nov; 5(17):4625-36. PubMed ID: 16220531
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
[TBL] [Abstract][Full Text] [Related]
11. Serum proteome analysis for profiling protein markers associated with lymph node metastasis in colorectal carcinoma.
Zhao L; Liu Y; Sun X; Peng K; Ding Y
J Comp Pathol; 2011; 144(2-3):187-94. PubMed ID: 21074777
[TBL] [Abstract][Full Text] [Related]
12. [Two-dimensional gel electrophoresis profiles of human normal prostate cells successfully established by 2-DE coupled with laser capture microdissection].
Li Q; Li YL; Yang XY; Zhang HY; Li HM; Li YL
Zhonghua Nan Ke Xue; 2007 Dec; 13(12):1064-7. PubMed ID: 18284050
[TBL] [Abstract][Full Text] [Related]
13. [Detection of serum biomakers of osteosarcoma by proteomic profiling].
Shen JN; Jin S; Wang J; Huang G; Yin JQ; Guo QC; Li HM; Liu W; Liu SJ; Li MT
Zhonghua Zhong Liu Za Zhi; 2008 Jul; 30(7):519-22. PubMed ID: 19062719
[TBL] [Abstract][Full Text] [Related]
14. Unfavorable prognostic value of human PEDF decreased in high-grade prostatic intraepithelial neoplasia: a differential proteomics approach.
Qingyi Z; Lin Y; Junhong W; Jian S; Weizhou H; Long M; Zeyu S; Xiaojian G
Cancer Invest; 2009 Aug; 27(7):794-801. PubMed ID: 19637042
[TBL] [Abstract][Full Text] [Related]
15. Down-regulated expression of complement factor I: a potential suppressive protein for gastric cancer identified by serum proteome analysis.
Liu W; Liu B; Xin L; Zhang Y; Chen X; Zhu Z; Lin Y
Clin Chim Acta; 2007 Feb; 377(1-2):119-26. PubMed ID: 17067565
[TBL] [Abstract][Full Text] [Related]
16. Application of surface-enhanced laser desorption/ionization time-of-flight-based serum proteomic array technique for the early diagnosis of prostate cancer.
Pan YZ; Xiao XY; Zhao D; Zhang L; Ji GY; Li Y; Yang BX; He DC; Zhao XJ
Asian J Androl; 2006 Jan; 8(1):45-51. PubMed ID: 16372118
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of differential proteins in laryngeal carcinoma cell line Hep-2 with transfection of LCRG1].
Zhang XP; Xiao ZQ; Chen ZC; Li C; Li JL; Yu YH; Ouyang YM; Feng XP; Zhang PF
Ai Zheng; 2006 Jan; 25(1):22-8. PubMed ID: 16405744
[TBL] [Abstract][Full Text] [Related]
18. Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/ MALDI-TOF/TOF and data validation by routine clinical assays.
Huang HL; Stasyk T; Morandell S; Dieplinger H; Falkensammer G; Griesmacher A; Mogg M; Schreiber M; Feuerstein I; Huck CW; Stecher G; Bonn GK; Huber LA
Electrophoresis; 2006 Apr; 27(8):1641-50. PubMed ID: 16550499
[TBL] [Abstract][Full Text] [Related]
19. [Serum proteomic variation study in patients with Crohn disease].
Kang L; Yang ZL; Liu W; Zhang LJ; Liu SJ; Huang MJ; Li MT; Wang JP
Zhonghua Wei Chang Wai Ke Za Zhi; 2008 May; 11(3):266-9. PubMed ID: 18478474
[TBL] [Abstract][Full Text] [Related]
20. 2D-DIGE as a strategy to identify serum markers for the progression of prostate cancer.
Byrne JC; Downes MR; O'Donoghue N; O'Keane C; O'Neill A; Fan Y; Fitzpatrick JM; Dunn M; Watson RW
J Proteome Res; 2009 Feb; 8(2):942-57. PubMed ID: 19093873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
